Hywin Holdings Ltd. (“Hywin” or the "Company") (NASDAQ: HYW) today announced its unaudited financial results for the first half of fiscal year 2024 ended December 31, 2023.

The Company’s businesses and operations in China faced significant headwinds as changes in the asset management industry, overall asset valuation levels in China and the economic environment presented challenges for the Company. The redemption issues of the asset-backed products business, which the Company has now discontinued, caused disruption to Hywin’s brand and operations and affected the confidence of clients, which resulted in a significant decline in total revenues and materially negative impact on bottom line, and adversely impacted results of operations and financial conditions during the reporting period.

As previously disclosed by the Company in our Form 6-K filed on December 14, 2023, with respect to the redemption issues of asset-backed products Hywin had historically distributed, while the Hywin Wealth Management Co. Ltd (“Hywin Wealth”), a variable interest entity in China, acted only as distributor of these products, Hywin Wealth continues to actively address these redemption issues on an ongoing basis by proactively coordinating with asset managers, relationship managers and clients to seek solutions and reduce client losses. In light of the overall liquidity conditions of the asset management industry in China, the Company estimates that it could take several years to coordinate asset managers and all clients to reach settlement.

The Company also announced on March 27, 2024, that our Board of Directors has approved the exit from the asset-backed products business in China, and furthermore on June 28, 2024, that our Board of Directors has approved a complete exit from the wealth management and asset management business. The Company has terminated its contractual arrangements with Hywin Wealth. As a result of such termination, Hywin Wealth has ceased to be a consolidated entity of the Company. The Company also announced that it will focus on new, innovative business models in the technology sector, including, among others, new retail, social e-commerce, and metaverse industries, and is planning to change its name from Hywin Holdings Ltd. to Santech Holdings Limited, subject to shareholder approval in an extraordinary general meeting to be held in due course.

The Company believes its business transformation will open up new opportunities for the Company. However, there are inherent uncertainties associated with such a business transformation. The Company anticipates a significant reduction in operational scale and revenue scale to persist in the near term.

First Half of Fiscal Year 2024 Highlights

  • Total revenues in the six months ended December 31, 2023 decreased by 23.6% to RMB791.2 million (US$110.5 million) from RMB1,036.0 million in the same period of 2022.

Hywin Wealth

  • Transaction value from discontinued business in the six months ended December 31, 2023 decreased by 38.1% to RMB24.9 billion from RMB40.2 billion in the same period of 2022.
    • Transaction value of asset-backed products in the six months ended December 31, 2023 decreased by 48.1% to RMB19.6 billion from RMB37.8 billion in the same period of 2022.
    • Transaction value of private market investment products, other than asset-backed products, in the six months ended December 31, 2023 increased by 151.9% to RMB1,977.6 million from RMB785.0 million in the same period of 2022.
    • Transaction value of public market investment products in the six months ended December 31, 2023 increased by 111.0% to RMB3,353.0 million from RMB1,588.9 million in the same period of 2022.
  • Transaction value of insurance products, which mainly refers to overseas insurance products, in the six months ended December 31, 2023 increased by 52.6% to RMB254.1 million from RMB166.5 million in the same period of 2022.
  • Credit loss in the six months ended December 31, 2023 were RMB449.0 million (US$62.7 million), mainly consisting of provisions recognized on the accounts receivable from asset managers of asset-backed products, and to a smaller extent, domestic insurance products.
  • Asset management business demonstrated continued growth in Assets Under Management ("AUM”) and net revenues. Net revenues from asset management business in the six months ended December 31, 2023 increased by 14.6% to RMB18.6 million (US$2.6 million) from RMB16.2 million in the same period of 2022.

Hywin Health

  • Number of Hywin Health clients1 was 39,598 as of December 31, 2023.
  • Net revenues from Hywin Health business segment in the six months ended December 31, 2023, increased by 83.1% to RMB70.12 million (US$9.8 million) from RMB38.3 million in the same period of 2022.
  • Number of medical examination visits was 2,721 in the six months ended December 31, 2023, which generated revenue of RMB8.3 million.
  • Number of health management service clients was 3,302 in the six months ended December 31, 2023, which generated revenue of RMB61.8 million.
  • Impairment losses on goodwill and on long-lived assets were RMB257.7 million and RMB210.9 million respectively, relating to our previous health management acquisitions. In view of the adverse impacts to the Hywin brand, the cross-selling synergies between Hywin Wealth and Hywin Health clients, or any new client acquisition for Hywin Health, have been significantly affected. Therefore, the Company performed impairment tests on such assets as fixed-assets, intangible assets, construction in progress and goodwill to identify potential accounts for impairment. Through the impairment tests, the Company made provisions totaling RMB468.6 million for asset impairment losses, including goodwill and long-lived assets of RMB257.7 million and RMB210.9 million, respectively.

A summary of the operating results of Hywin Health’s business segment is as follows:

  6 months ended, 6 months ended, 6 months ended,
  12/31/2022 12/31/2023 12/31/2023
  RMB'000 RMB'000 USD'000
Net Revenues 38,304   70,146   9,798  
       
Operating Costs and Expenses      
-Health Management Cost 26,152   54,881   7,666  
-Sales and marketing expenses 9,395   14,061   1,964  
-General and administrative expenses 26,320   38,755   5,413  
-Credit Loss -   1,032   144  
-Impairment loss on goodwill -   257,712   35,997  
-Impairment loss on long lived assets -   210,916   29,460  
Total Operating Costs and Expenses 61,867   577,357   80,644  
       
Net Loss (24,197 ) (491,502 ) (68,652 )

First Half of Fiscal Year 2024 Financial Results

Net Revenues

Total revenues in the six months ended December 31, 2023 decreased by 23.6% to RMB791.2 million (US$110.5 million) from RMB1,036.0 million in the same period of 2022, mainly due to decreases in net revenues from wealth management business resulting from a weak economic and industry environment, as well as the redemption issues reported in December 2023. The decreases were partially offset by revenue growth from Hywin Health and asset management business.

  • Net revenues from wealth management services in the six months ended December 31, 2023 decreased by 28.1% to RMB697.8 million (US$97.5 million) from RMB970.2 million in the same period of 2022, in line with the decrease in transaction value.
    • Net revenues from insurance brokerage services, which mainly refers to overseas insurance products, in the six months ended December 31, 2023 increased by 122.1% to RMB151.3 million (US$21.1 million) from RMB68.1 million in the same period of 2022, mainly due to surging insurance demand post Covid reopening.
  • Net revenues from asset management services in the six months ended December 31, 2023 increased by 14.6% to RMB18.6 million (US$2.6 million) from RMB16.2 million in the same period of 2022, primarily due to an increase in AUM.
  • Net revenues from Hywin Health business segment in the six months ended December 31, 2023 increased by 83.1% to RMB70.1 million (US$9.8 million) from RMB38.3 million in the same period of 2022, in line with our strategic emphasis on health management before the redemption that occurred in December 2023.

Operating Costs and Expenses

Total operating costs and expenses in the six months ended December 31, 2023 increased by 101.0% to RMB1,876.9 million (US$262.2 million) from RMB933.9 million in the same period of 2022, primarily due to credit loss resulting from redemption issues and impairment loss on goodwill and long lived assets, as well as investments in health-related business.

  • Cost of compensation and benefits in the six months ended December 31, 2023 decreased by 19.4% to RMB464.1 million (US$64.8 million) from RMB576.2 million in the same period of 2022, in line with the decreases in the transaction value of wealth management business, partially offset by higher commission from insurance brokerage services.
  • Costs related to Hywin Health business segment in the six months ended December 31, 2023 increased by 109.9% to RMB54.9 million (US$7.7 million) from RMB26.2 million, in line with our increased investments to improve our health management product offerings during the reporting period.
  • Sales and marketing expenses in the six months ended December 31, 2023 decreased by 14.6% to RMB155.8 million (US$21.8 million) from RMB182.6 million in the same period of 2022, due to reduced marketing and sales activities of Hywin Wealth as a result of the decreased budget related to the decrease in transaction value.
  • General and administrative expenses in the six months ended December 31, 2023 increased by 10.3% to RMB161.3 million (US$22.5 million) from RMB146.2 million in the same period of 2022, primarily due to new expenses related to health services.
  • Credit loss in the six months ended December 31, 2023 were RMB449.0 million (US$62.7 million), mainly consisting of provisions recognized on the accounts receivable from asset managers of asset-backed products, and to a smaller extent, domestic insurance products.
  • Impairment loss on goodwill in the six months ended December 31, 2023 were RMB257.7 million (US$36.0 million), due to the performance metrics of Grand Doctor, Beijing iLife 3 Technology Co., Ltd. (“Life Infinity”), and Sincerity and Compassion Health Management Center (“Sincerity and Compassion”) failing to meet our established expectations after the acquisitions, particularly since Hywin’s brand has suffered adverse impacts as a result of the redemption issues in the wealth management segment.
  • Impairment loss on long lived assets in the six months ended December 31, 2023 were RMB332.4 million (US$46.4 million), due to the performance metrics of Grand Doctor, Life Infinity and Sincerity and Compassion failing to meet our established expectations after the acquisitions, particularly since Hywin’s brand has suffered adverse impacts as a result of the redemption issues in the wealth management segment. Impairment losses were also recorded because events or changes in circumstances led us to believe that expected future cash flow generated by the fixed-assets, intangible assets and construction in progress will be less than carrying amount.
  • Impairment loss on long term investment in the six months ended December 31, 2023 were RMB1.0 million (US$0.14 million), due to failure to achieve the expected return of the long-term investment by Shenzhen Panying Asset Management Co., Ltd.

Loss from Operations

As a result of the foregoing, loss from operations in the six months ended December 31, 2023 was RMB1,085.7 million (US$151.6 million), compared to income from operations of RMB102.1 million in the same period of 2022, attributable to the decreases in net revenues and the increases in operating costs and expenses.

Net Loss

Net loss in the six months ended December 31, 2023 was RMB1,068.8 million (US$149.3 million), compared with net income of RMB70.6 million in the same period of 2022.

Loss per ADS

Basic loss per ADS in the six months ended December 31, 2023 was RMB38.09 (US$5.32), compared with basic earnings per ADS of RMB2.59 in the same period of 2022.

Diluted loss per ADS in the six months ended December 31, 2023 was RMB38.09 (US$5.32), compared with diluted earnings per ADS of RMB2.51 in the same period of 2022.

Each ADS represents two of the Company’s ordinary shares.

Balance Sheet

As of December 31, 2023, the Company had RMB330.0 million (US$46.6 million) in cash, cash equivalents, and restricted cash, compared with RMB945.9 million as of June 30, 2023. The decrease was mainly attributable to our operating loss and the uncollectible accounts receivable of asset-backed products during the reporting period, as well as our acquisition of the land use rights of a real property in Boao, Hainan Province, in September 2023.

As of December 31, 2023, the Company had RMB261.5 million (US$36.9 million) in property and equipment, RMB15.4 million (US$2.2 million) in intangible assets, and RMB129.2 million (US$18.2 million) in land use right compared with RMB349.7 million in property and equipment, RMB98.6 million in intangible assets and nil in land use right as of June 30, 2023.

As of December 31, 2023, the Company had RMB2.3 million (US$0.3 million) in deferred tax liability compared with RMB20.0 million as of June 30, 2023.

Subsequent Event

In March 2024, the Company was named as a defendant in a securities class action complaint filed in the New York County Supreme Court alleging violations of the Securities Act of 1933. The Company disputes each and every claim and intends to defend against such allegations vigorously.

Exchange Rate

This press release contains translations of certain RMB amounts into U.S. dollars at specified rates solely for the convenience of readers. Unless otherwise noted, all translations from RMB to U.S. dollars in this press release were made at a rate of RMB7.08273 to US$1.00, for figures on the balance sheet as of December 31, 2023, RMB7.15934 to US$1.00 for figures on the income statement for the six months ended December 31, 2023.

About Hywin Holdings Ltd.

Hywin Holdings Limited, to be renamed Santech Holdings Limited, is a consumer-focused technology company. The Company historically served a large number of high net-worth clients in China in financial services and health management, and accumulated a large customer base. The Company has exited or disposed of its historical businesses in financial services and is actively exploring innovative new opportunities in technology, including but not limited to new retail, social e-commerce and metaverse. For more information, please visit https://ir.hywinwealth.com.

Safe Harbor Statement

This press release contains statements that may constitute “forward-looking” statements pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “anticipate,” “estimate,” “forecast,” “plan,” “project,” “potential,” “continue,” “ongoing,” “expect,” “aim,” “believe,” “intend,” “may,” “should,” “will,” “is/are likely to,” “could” and similar statements. Statements that are not historical facts, including statements about the Company's beliefs, plans, and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Further information regarding these and other risks is included in the Company's filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

Investor Contact:Hywin Holdings Ltd.Email: ir@hywinwealth.com  

Media Contact:ICR, LLCEdmond LococoPhone: +86 138-1079-1408Email: HywinPR@icrinc.com

1 Clients are those who have historically used Hywin Health’s services at least once.2 Health segment revenues before inter segment transactions elimination.3 China Foreign Exchange Trade System USD/RMB mid-point rate on December 31, 2023.4 An appropriately weighted average exchange rate for the reporting period.

HYWIN HOLDINGS LTD. CONSOLIDATED BALANCE SHEETS  
 
 (unaudited)  
         
  6/30/2023 12/31/2023 12/31/2023  
  RMB'000 RMB'000 USD'000  
ASSETS        
Current assets        
Cash and cash equivalents 868,908 309,495   43,697    
Restricted cash 76,975 20,483   2,892    
Term deposit 28,903 78,331   11,059    
Accounts receivable, net 415,134 152,371   21,512    
Deposits, prepayments and other current assets 46,392 44,433   6,275    
Contract assets 33,491 27,442   3,875    
Total Current Assets 1,469,803 632,556   89,310    
         
Non-current assets        
Property and equipment, net 349,685 261,518   36,923    
Long-term investment 1,000 -   -    
Intangible assets, net 98,603 15,398   2174    
Goodwill 257,712 -   -    
Long-term prepayments 9,657 -   -    
Deferred tax asset, net 725 401   5    
Operating lease right-of-use assets 186,307 3,180   449    
Land use right - 129,210   18,243    
Total Non-current Assets 903,689 409,707   57,846    
         
Total Assets 2,373,492 1,042,263   147,156    
         
LIABILITIES AND SHAREHOLDERS’ EQUITY      
Current Liabilities        
Commission payable 172,456 111,107   15,687    
Accounts payable 3,332 5,295   748    
Advance from customers 39,812 36,304   5,126    
Investors’ deposit 70,934 6,308   891    
Income tax payable 167,798 165,120   23,313    
Due to related parties 38,073 38,462   5,430    
Other payable and accrued liabilities 433,217 335,107   47,313    
Operating lease liabilities 83,573 97,356   13,746    
Total Current Liabilities 1,009,195 795,059   112,254    
         
Non-current liabilities        
Commission payable-non current 526 -   -    
Deferred tax liability 20,028 2,293   324    
Operating lease liabilities, non-current 100,521 73,066   10,316    
Total Non-current Liabilities 121,075 75,359   10,640    
         
Total Liabilities 1,130,270 870,418   122,894    
         
Mezzanine equity        
Redeemable noncontrolling interest 30,600 30,600   4,320    
Total Mezzanine equity 30,600 30,600   4,320    
           
Shareholders' Equity        
Ordinary shares 36 36   5    
Additional paid-in capital 515,665 516,390   72,909    
Statutory reserves 128,297 128,297   18,114    
Accumulated gain (deficit) 451,013 (615,388 ) (86,886 )  
Noncontrolling interest 100,931 98,564   13,916    
Other comprehensive income 16,680 13,346   1,884    
Total Shareholders' equity 1,212,622 141,245   19,942    
         
Total Liabilities, Mezzanine equity and Shareholder's equity 2,373,492 1,042,263   147,156    
HYWIN HOLDINGS LTD. CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME  
 
(In thousands, except for per ADS data and percentages)  
(unaudited)  
             
  6 months ended,   6 months ended,   6 months ended,     Change  
  12/31/2022   12/31/2023   12/31/2023      
  RMB'000   RMB'000   USD'000      
Net Revenues            
-Wealth management 970,157   697,847   97,474     (28.1 )%  
-Assets management 16,203   18,572   2,594     14.6 %  
-Health management 38,304   67,261   9,395     75.6 %  
-Other 11,320   7,547   1,054     (33.3 )%  
 Total Revenue 1,035,984   791,227   110,517     (23.6 )%  
             
Operating Costs and Expenses            
-Compensation and benefits 576,173   464,131   64,829     (19.4 )%  
-Health management costs 26,152   54,881   7,666     109.9 %  
-Share-based compensation 2,804   725   101     (74.1 )%  
-Sales and marketing expenses 182,553   155,817   21,764     (14.6 )%  
-General and administrative expenses 146,243   161,288   22,528     10.3 %  
-Credit Loss   448,982   62,713     N/A    
-Impairment loss on goodwill -   257,712   35,997     N/A    
-Impairment loss on long lived assets -   332,371   46,425     N/A    
-Impairment loss on long term investment   1,000   140     N/A    
Total Operating Costs and Expenses 933,925   1,876,907   262,163     101.0 %  
             
Income (Loss) from operations 102,059   (1,085,680 ) (151,646 )   (1163.8 )%  
             
Other (expenses)/income            
-Interest income, net 549   (396 ) (55 )   (172.1 )%  
-Other non-operation income, net (4,559 ) (63 ) (9 )   (98.6 )%  
Total Other (Expense) Income (4,010 ) (459 ) (64 )   (88.6 )%  
             
Income (Loss) before tax 98,049   (1,086,139 ) (151,710 )   (1207.8 )%  
Income tax expense (benefits) 27,467   (17,371 ) (2,426 )   (163.2 )%  
Net income (loss) 70,582   (1,068,768 ) (149,284 )   (1614.2 )%  
             
Less: net loss attributable to non-controlling interests (2,033 ) (2,367 ) (331 )   16.4 %  
Net income/(loss) attributable to shareholders 72,615   (1,066,401 ) (148,953 )   (1568.6 )%  
             
Other comprehensive Income (loss)            
-Foreign currency translation (loss)/gain 2,456   (3,334 ) (466 )   (235.7 )%  
Comprehensive Income (loss) 73,038   (1,072,102 ) (149,750 )   (1567.9 )%  
             
Less: Comprehensive Loss attributable to non-controlling interests (2,033 ) (2,367 ) (331 )   16.4 %  
Comprehensive Income (Loss) attributable to shareholders 75,071   (1,069,735 ) (149,419 )   (1525.0 )%  
             
 Income (Loss) per ADS            
 Income (Loss) per ADS basic 2.59   (38.09 ) (5.32 )   (1570.7 )%  
 Income (Loss) per ADS diluted 2.51   (38.09 ) (5.32 )   (1617.5 )%  
                     

The Board of Directors has approved the termination of VIE agreements with Hywin Wealth Management Co., Ltd. on June 28, 2024, which resulted in the discontinued operation of onshore wealth management businesses.

The following unaudited and unreviewed pro forma consolidated financial information reflects adjustments to the Company’s historical financial results as reported under U.S. GAAP, in connection with the termination of asset-backed products business. The unaudited and unreviewed pro forma consolidated statement of comprehensive income for the year ended June 30, 2023, has been prepared with the assumption that the termination of asset-backed products business was completed as of July 1, 2022, and the effects of the transaction are carried forward to the unaudited and unreviewed pro forma consolidated statement of comprehensive income for the six months ended December 31, 2023. The unaudited and unreviewed pro forma consolidated balance sheet as of December 31, 2023, has been prepared with the assumption that the termination of asset-backed products business was consummated on that date.

The consolidated “as reported” column in the unaudited and unreviewed pro forma balance sheet and in the unaudited and unreviewed pro forma statement of comprehensive income reflects the Company’s historical financial statements for the periods presented. Assumptions and estimates underlying the pro forma adjustments column are described in the accompanying notes.

The unaudited and unreviewed pro forma consolidated financial information does not purport to be indicative of the results of operations or the financial condition which would have actually resulted if the termination of asset-backed products business actually occurred on the dates presented or to project our results of operations or financial position for any future period. This financial information may not be predictive of the future results of operations or financial condition of the Company, as the Company’s future results of operation and financial condition may differ significantly from the pro forma amounts reflected herein due to a variety of factors.

The unaudited and unreviewed pro forma financial information has been prepared by the Company based upon assumptions deemed appropriate by the Company’s management and are based upon information and assumptions available at the time of filing the Company’s current report on Form 6-K filed with the SEC on June 28, 2024. The following unaudited and unreviewed pro forma financial information should be read in conjunction with: (i) the accompanying notes to the unaudited and unreviewed pro forma consolidated financial information; and (ii) the audited consolidated financial statements of the Company which were included in the Company’s annual report on Form 20-F filed with the SEC on October 18, 2023 and the Company’s unaudited interim report on Form 6-K filed with the SEC on June 28, 2024.

HYWIN HOLDINGS LTD.  PRO FORMA CONSOLIDATED BALANCE SHEETS As of December 31, 2023  
 (unaudited and unreviewed)  
      Pro forma Adjustments          
  Consolidated   Discontinued       Pro forma   Pro forma  
  Company as   Business       Consolidated   Consolidated  
  Reported   Disposition       Company   Company  
  RMB'000   RMB'000       RMB'000   USD'000  
ASSETS                    
Current assets                    
 Cash and cash equivalents 309,495     -         309,495     43,697    
 Restricted cash 20,483     -         20,483     2,892    
 Term deposit 78,331     -         78,331     11,059    
 Accounts receivable, net 152,371     (97,952 )       54,419     7,683    
 Due from related parties, net -     (750,809 )   (1)   -     -    
 Deposits, prepayments and other current assets 44,434     (24,642 )       19,792     2,795    
 Contract assets 27,442     -         27,442     3,875    
Total Current Assets 632,556     (873,403 )       509,962     72,001    
                     
Non-current assets                    
Property and equipment, net 261,518     (261,494 )       24     3    
Long term investment -     -     (2)   -     -    
Intangible assets, net 15,398     -         15,398     2,174    
Deferred tax asset, net 401     (401 )       -     -    
Operating lease right-of-use assets 3,180     -         3,180     449    
Held for sale assets 129,210     -         129,210     18,243    
Total Non-current Assets 409,707     (261,895 )       147,812     20,869    
                     
Total Assets 1,042,263     (1,135,298 )       657,774     92,870    
                     
LIABILITIES AND SHAREHOLDERS’ EQUITY                    
Current Liabilities                    
Commission payable 111,107     (69,716 )       41,391     5,844    
Accounts payable 5,295     -         5,295     748    
Advance from customers 36,304     -         36,304     5,126    
Investors’ deposit 6,308     (6,308 )       -     -    
Income tax payable 165,120     (151,127 )       13,993     1,976    
Due to related parties 38,462     (22,819 )   (1)   766,452     108,214    
Other payable and accrued liabilities 335,107     (302,449 )       32,658     4,610    
Operating lease liabilities 97,356     (51,135 )       46,221     6,526    
Total Current Liabilities 795,059     (603,554 )       942,314     133,044    
                     
Non-current liabilities                    
Deferred tax liability 2,293     -         2,293     324    
Operating lease liabilities, non-current 73,066     (26,967 )       46,099     6,509    
Total Non-current Liabilities 75,359     (26,967 )       48,392     6,833    
                     
Total Liabilities 870,418     (630,521 )       990,706     139,877    
                     
Mezzanine equity                    
Redeemable noncontrolling interest 30,600     -         30,600     4,320    
Total Mezzanine equity 30,600     -         30,600     4,320    
                     
Shareholders' Equity                    
Ordinary shares 36     -     (2)   36     5    
Additional paid-in capital 516,390     (295,533 )   (2)   220,857     31,183    
Statutory reserves 128,297     (128,254 )   (2)   43     6    
Accumulated gain (615,388 )   (80,990 )   (2)   (696,378 )   (98,321 )  
Noncontrolling interest 98,564     -         98,564     13,916    
Other comprehensive income 13,346     -         13,346     1,884    
                     
Total Shareholders' equity 141,245     (504,777 )       (363,532 )   (51,327 )  
                     
Total Liabilities, Mezzanine equity and Shareholder's equity 1,042,263     (1,135,298 )       657,774     92,870    
                             

See Notes to the Unaudited and Unreviewed Pro Forma Consolidated Financial Statements.

 HYWIN HOLDINGS LTD. PRO FORMA CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME  
 For the Six Months Ended December 31, 2023  
 (unaudited and unreviewed)  
      Pro forma Adjustments        
  Consolidated   Discontinued       Pro forma   Pro forma  
  Company as   Business       Consolidated   Consolidated  
  Reported   Disposition       Company   Company  
  RMB'000   RMB'000       RMB'000   USD'000  
Net Revenues                    
-Wealth management 697,847     (545,571 )       152,276     21,270    
-Assets management 18,572     -         18,572     2,594    
-Health Management 67,261     2,885     (3)   70,146     9,798    
-Other 7,547     29,115     (3)   36,662     5,121    
Total Revenue 791,227     (513,571 )       277,656     38,783    
                     
Operating Costs and Expenses                    
-Compensation and benefits 464,131     (374,129 )   (3)   90,002     12,571    
-Health management costs 54,881     -         54,881     7,666    
-Share-based compensation 725     -         725     101    
-Sales and marketing expenses 155,817     (130,026 )   (3)   25,791     3,602    
-General and administrative expenses 161,288     (64,068 )   (3)   97,220     13,580    
-Credit Loss 448,982     (436,164 )       12,818     1,790    
-Impairment loss on goodwill 257,712     -         257,712     35,997    
-Impairment loss on long lived assets 332,371     (116,704 )       215,667     30,124    
-Impairment loss on long term investment 1,000     -         1,000     140    
Total Operating Costs and Expenses 1,876,907     (1,121,091 )       755,816     105,571    
                     
Loss from operations (1,085,680 )   607,520         (478,160 )   (66,788 )  
                     
Other (expenses)/income                    
-Interest (expense)/income, net (396 )   (516 )       (912 )   (127 )  
-Other non-operation (expense)/income, net (63 )   1,994         1,931     270    
Total Other (Expenses)/Income (459 )   1,478         1,019     143    
                     
Loss before tax (1,086,139 )   608,998         (477,141 )   (66,645 )  
Income tax expense (17,371 )   (324 )       (17,695 )   (2,471 )  
Net Loss (1,068,768 )   609,322         (459,446 )   (64,174 )  
                     
Less: net loss attributable to non-controlling interests (2,367 )   -         (2,367 )   (331 )  
Net loss attributable to shareholders (1,066,401 )   609,322         (457,079 )   (63,843 )  
                     
Other comprehensive loss                    
-Foreign currency translation loss (3,334 )   -         (3,334 )   (466 )  
Comprehensive Loss (1,072,102 )   609,322         (462,780 )   (64,640 )  
                     
 Less: Comprehensive Loss attributable to non-controlling interests (2,367 )   -         (2,367 )   (331 )  
Comprehensive Loss attributable to shareholders (1,069,735 )   609,322         (460,413 )   (64,309 )  
                             

See Notes to the Unaudited and Unreviewed Pro Forma Consolidated Financial Statements.

 HYWIN HOLDINGS LTD. PRO FORMA CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME  
 For the twelve Months Ended June 30, 2023  
 (unaudited and unreviewed)  
      Pro forma Adjustments           
  Consolidated    Discontinued        Pro forma   Pro forma  
  Company as    Business        Consolidated   Consolidated  
  Reported    Disposition        Company   Company  
  RMB'000    RMB'000        RMB'000   USD'000  
Net Revenues                    
-Wealth management 1,949,410     (1,741,684 )       207,726     29,919    
-Assets management 32,562     -         32,562     4,690    
-Health Management 86,464     1,377     (3)   87,841     12,652    
-Other 23,321     49,553     (3)   72,874     10,496    
 Total Revenue 2,091,757     (1,690,754 )       401,003     57,757    
                     
Operating Costs and Expenses                    
-Compensation and benefits 1,156,381     (1,038,326 )   (3)   118,055     17,004    
-Health management costs 74,476     -         74,476     10,727    
-Share-based compensation 5,207     -         5,207     750    
-Sales and marketing expenses 318,465     (278,515 )   (3)   39,950     5,754    
-General and administrative expenses 302,221     (149,010 )   (3)   153,211     22,067    
-Impairment loss on goodwill 35,412     -         35,412     5,100    
-Impairment loss on long lived assets 2,210     -         2,210     318    
Total Operating Costs and Expenses 1,894,372     (1,465,851 )       428,521     61,720    
                     
Income/(Loss) from operations 197,385     (224,903 )       (27,518 )   (3,963 )  
                     
Other (expenses)/income                    
-Interest income, net 1,348     (668 )       680     98    
-Other non-operation expense, net (7,083 )   612         (6,471 )   (932 )  
Total Other (Expenses)/Income (5,735 )   (56 )       (5,791 )   (834 )  
                     
Income/(loss) before tax 191,650     (224,959 )       (33,309 )   (4,797 )  
Income tax expense 71,380     (59,403 )       11,977     1,725    
Net Income/(Loss) 120,270     (165,556 )       (45,286 )   (6,522 )  
                     
Less: net loss attributable to non-controlling interests (9,611 )   -         (9,611 )   (1,384 )  
Net income/(loss) attributable to shareholders 129,881     (165,556 )       (35,675 )   (5,138 )  
                     
Other comprehensive Income                    
-Foreign currency translation gain 8,222     -         8,222     1,184    
Comprehensive Income/(Loss) 128,492     (165,556 )       (37,064 )   (5,338 )  
                             
Less: Comprehensive Loss attributable to non-controlling interests (9,611 )   -         (9,611 )   (1,384 )  
Comprehensive Income/(Loss) 138,103     (165,556 )       (27,453 )   (3,954 )  
                             

See Notes to the Unaudited and Unreviewed Pro Forma Consolidated Financial Statements.

 HYWIN HOLDINGS LTD. PRO FORMA CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME
 For the twelve Months Ended June 30, 2022
 (unaudited and unreviewed)
      Pro forma Adjustments             
  Consolidated   Discontinued       Pro forma   Pro forma
  Company as   Business       Consolidated   Consolidated
  Reported   Disposition       Company   Company
  RMB'000   RMB'000       RMB'000   USD'000
Net Revenues                  
-Wealth management 1,899,573     (1,851,107 )       48,466     7,506  
-Assets management 19,476     -         19,476     3,016  
-Health Management 422     -     (3)   422     65  
-Other 22,642     34,479     (3)   57,121     8,847  
 Total Revenue 1,942,113     (1,816,628 )       125,485     19,434  
                   
Operating Costs and Expenses                  
-Compensation and benefits 1,050,077     (1,007,755 )   (3)   42,322     6,555  
-Health management costs 4,287     -         4,287     664  
-Share-based compensation 7,340     -         7,340     1,137  
-Sales and marketing expenses 311,773     (293,334 )   (3)   18,439     2,856  
-General and administrative expenses 241,946     (169,177 )   (3)   72,769     11,270  
Total Operating Costs and Expenses 1,615,423     (1,470,266 )       145,157     22,482  
                   
Income/(Loss) from operations 326,690     (346,362 )       (19,672 )   (3,048 )
                   
Other (expenses)/income                  
-Interest income, net 1,498     (870 )       628     97  
-Other non-operation (expense)/income, net (3,741 )   (6,093 )       (9,834 )   (1,523 )
Total Other (Expenses)/Income (2,243 )   (6,963 )       (9,206 )   (1,426 )
                   
Income/(loss) before tax 324,447     (353,325 )       (28,878 )   (4,474 )
Income tax expense 88,578     (85,522 )       3,056     473  
Net Income/(Loss) 235,869     (267,803 )       (31,934 )   (4,947 )
                   
Net income/(loss) attributable to shareholders 235,869     (267,803 )       (31,934 )   (4,947 )
                   
Other comprehensive Income                  
-Foreign currency translation gain 4,177     (866 )   (3)   3,311     513  
Comprehensive Income/(Loss) 240,046     (268,669 )       (28,623 )   (4,434 )
                   
Comprehensive Income attributable to shareholders 240,046     (268,669 )       (28,623 )   (4,434 )
                           

See Notes to the Unaudited and Unreviewed Pro Forma Consolidated Financial Statements.

 HYWIN HOLDINGS LTD. PRO FORMA CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME  
 For the twelve Months Ended June 30, 2021  
 (unaudited and unreviewed)  
      Pro forma Adjustments             
  Consolidated    Discontinued      Pro forma   Pro forma  
  Company as    Business      Consolidated   Consolidated  
  Reported    Disposition      Company   Company  
  RMB'000    RMB'000      RMB'000   USD'000  
Net Revenues                  
-Wealth management 1,795,552   (1,742,129 )     53,423     8,070    
-Assets management 14,942   -       14,942     2,257    
-Other 23,928   (1,286 )     22,642     3,421    
 Total Revenue 1,834,422   (1,743,415 )     91,007     13,748    
                   
Operating Costs and Expenses                  
-Compensation and benefits 1,003,061   (962,550 )     40,511     6,120    
-Share-based compensation 21,947   -       21,947     3,315    
-Sales and marketing expenses 326,879   (311,849 )     15,030     2,270    
-General and administrative expenses 200,929   (144,849 )     56,080     8,472    
Total Operating Costs and Expenses 1,552,816   (1,419,248 )     133,568     20,177    
                   
Income/(Loss) from operations 281,606   (324,167 )     (42,561 )   (6,429 )  
                   
Other Income/(Expenses)                  
-Interest income, net 1,537   (1,484 )     53     8    
-Other non-operation income/(expense), net 12,608   (13,207 )     (599 )   (90 )  
Total Other Income/(Expenses) 14,145   (14,691 )     (546 )   (82 )  
                   
Income/(loss) before tax 295,751   (338,858 )     (43,107 )   (6,511 )  
Income tax expense 88,094   (88,301 )     (207 )   31    
Net Income/(Loss) 207,657   (250,557 )     (42,900 )   (6,480 )  
                   
Net income/(loss) attributable to shareholders 207,657   (250,557 )     (42,900 )   (6,480 )  
                     
Other comprehensive Income                  
-Foreign currency translation gain 10,542   -       10,542     1,592    
Comprehensive Income/(Loss) 218,199   (250,557 )     (32,358 )   (4,888 )  
                   
Comprehensive Income/(Loss) attributable to shareholders 218,199   (250,557 )     (32,358 )   (4,888 )  
                   

See Notes to the Unaudited and Unreviewed Pro Forma Consolidated Financial Statements.

NOTES TO UNAUDITED and UNREVIEWED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS

The pro forma adjustments are based on preliminary estimates and assumptions by management that may be subject to change. The following adjustments have been reflected in the unaudited and unreviewed pro forma consolidated financial information:

(1) Adjustment to reflect the elimination of assets and liabilities attributable to the Discontinued business.

(2) Adjustment to reflect the long-term investment in subsidiaries.

(3) Adjustment to reflect the elimination of internal consulting and technology revenue related to the Discontinued business.

Grafico Azioni Hywin (NASDAQ:HYW)
Storico
Da Ott 2024 a Nov 2024 Clicca qui per i Grafici di Hywin
Grafico Azioni Hywin (NASDAQ:HYW)
Storico
Da Nov 2023 a Nov 2024 Clicca qui per i Grafici di Hywin